Maharashtra FDA suspends Zepto's Food Business license in Dharavi after hygiene violations
Zepto, the fast-growing quick-commerce platform, has had its food business license suspended at its Dharavi facility in Mumbai. The Maharashtra Food and Drug Administration (FDA) took strict action following an inspection that revealed multiple food safety violations.
According to the FDA, Kiranakart Technologies (Zepto) was found violating key provisions of the Food Safety and Standards Act, 2006, and the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations, 2011. Inspectors observed fungal growth on food items and discovered that products were stored near clogged water, creating unhygienic and unsafe conditions.
The FDA inspection further noted poor maintenance of cold-storage temperatures, which did not comply with regulatory guidelines. Additionally, the facility had wet and dirty floors, and raw materials and food products were stored haphazardly. Expired food products were not separated from fresh stock, increasing the risk to consumer health.
The inspection was conducted based on information received from the Minister of State for FDA, Yogen Kadam. Following the findings, Anupamaa Balasaheb Patil, Assistant Commissioner (Food), ordered the immediate suspension of Zepto's food business license under Section 32(3) of the Food Safety and Standards Act, 2006, and Regulation 2.1.8(4) of the Licensing and Registration Regulations, 2011.
Zepto has not yet issued an official response. The food business license will remain suspended until the company rectifies all safety and hygiene issues and complies with FDA standards.
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
FDA grants de novo authorisation to Artera's prostate software
The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera's ArteraAI Prostate software. This marks it as an inaugural AI-powered software with the ability to predict long-term results for those with non-metastatic prostate cancer. This regulatory milestone categorises ArteraAI Prostate as a software as a medical device (SaMD) and enables the use of such AI-assisted tools in qualified pathology laboratories across the US. The authorisation also sets a new product code for similar future digital pathology risk-stratification applications. The FDA's decision includes a Predetermined Change Control Plan that allows the company to widen its platform by validating compatibility with more digital pathology scanners with no need for additional 510(k) submissions. The test was previously granted a breakthrough device designation by the US regulator. Artera's broader multimodal artificial intelligence (MMAI) platform is already on the market through ArteraAI as a laboratory-developed test (LDT). The MMAI biomarker test of the company utilises an algorithm that evaluates digital biopsy images and clinical data to forecast the efficacy of hormone therapy and estimate long-term patient outcomes. This algorithm is the product of extensive development, drawing from vast datasets, including various patients and pathology slides, and has been clinically validated through several Phase III randomised studies. Artera's portfolio also includes other MMAI-powered products such as the ArteraAI Prostate Biopsy Assay, ArteraAI Prostate, and ArteraAI Breast Test. Artera co-founder and CEO Andre Esteva said: 'The FDA's decision validates the power of our MMAI platform to deliver on our vision to create AI-guided tools that enable data-backed and tailored treatments for each patient, leading to more confidence throughout the cancer journey, and ultimately, save more lives.' In February 2025, Artera announced a partnership with Tempus to broaden the availability of the AI-based prostate cancer test. "FDA grants de novo authorisation to Artera's prostate software" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
36 minutes ago
- Yahoo
Coffee sold at Dollar General recalled for 'potential presence' of glass
Instant coffee products sold at Dollar General stores nationwide has been recalled due to the "potential presence of glass," according to the company. Dollar General has voluntarily recalled three lots of its 8-ounce Clover Valley Instant Coffee sold in 48 states, the company said in an announcement posted by the U.S. Food and Drug Administration. "The recall is being initiated after a customer notified Dollar General employees about the potential issue," the statement said. "Ingesting glass fragments may cause injury to the consumer, and these injuries may include damage to teeth, laceration of the mouth and throat, or perforation of the intestine. No illnesses or injuries have been reported to date." The recalled products were sold between July 9-21, 2025, and have the UPC number 876941004069 on the package. There are three specific codes that can be found on the neck of the jar: L-5163 and L-5164 that both have a Best By date of 12/13/2026; and L-5165 with a Best by of 12/14/2026. The Tennessee-based retailer has encouraged any customers who purchased the coffee products to discard it for a full refund. "Contact Dollar General either via email at customercare@ or by phone at 1-888-309-9030 from 6 a.m. to 1 a.m. CST seven days a week to request a full refund of the purchase price (including any tax)," the company stated. "Dollar General is actively investigating the source of the glass contamination and apologizes for any inconvenience caused by this product issue," the recall statement added. Dollar General did not immediately respond to an ABC News request for additional comment. Solve the daily Crossword
Fast Company
2 hours ago
- Fast Company
Don't drink this recalled instant coffee from Dollar General. It might contain something dangerous
Of all the things you don't want to find in a jar of instant coffee, glass is pretty high on the list. But that scenario became more than hypothetical after a customer alerted Dollar General employees to a 'potential issue' in their eight-ounce instant coffee. Now, Dollar General has issued a recall of three lots of the powdered drink due to the possibility of glass fragments. The recall impacts retailer's private label brand Clover Valley. 'Dollar General is actively investigating the source of the glass contamination and apologizes for any inconvenience caused by this product issue,' the chain said in a statement. The recall was also announced by the Food and Drug Administration (FDA). Here's everything you need to know about identifying the affected items. Which products are affected? The recalled coffee is the Clover Valley brand's eight-ounce instant coffee. It has a package UPC of 876941004069 and includes the following three lots: L-5163: Best by December 13, 2026 L-5164: Best by December 13, 2026 L-5165: Best by December 14, 2026 You can find this information on the neck of the jar. An image of the product can be found on the FDA's website. Where and when was the product sold? The coffee was exclusively sold in Dollar General retail stores between July 9 and 21, 2025, and across almost every state. Here's a complete list of the states where Dollar General has recalled its eight-ounce Clover Valley Instant Coffee: Alabama Arkansas Arizona California Colorado Connecticut Delaware Florida Georgia Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Michigan Minnesota Missouri Mississippi Montana North Carolina North Dakota Nebraska New Hampshire New Jersey New Mexico Nevada New York Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Virginia Vermont Washington Wisconsin West Virginia Wyoming If your imagination isn't detailed enough, Dollar General provides a graphic breakdown in its announcement of what can happen if you ingest glass. (We'll leave reading that to your discretion.) The company says it hasn't received any reports of injuries or illnesses. What should I do if I have this product? Don't drink it. Dollar General is offering a refund for anyone who bought the instant coffee. You can reach out for one through email at customercare@ The company can also process a refund over the phone every day from 6 a.m. to 1 a.m. at 1-888-309-9030.
